Regulators | Functions | Targeting drugs | Biomarkers | Literatures |
---|---|---|---|---|
ARE | •Counteract the harmful effects of reactive oxidants •Restore redox balance | |||
ASK1 | Regulate apoptosis signal | |||
ATF4 | Regulating the expression of genes involved in redox balance, amino acid metabolism, protein folding, autophagy and cell survival | CFZ&ACY-1215 | ||
ATF6 | Induce ER biogenesis, chaperone up-regulation and unfolded/misfolded proteins degradation | A biomarker to distinguish LGD from inflammatory regenerative epithelium in UC patients | ||
CHOP | Induce apoptosis | •Fucoidan •Small-molecule inhibitor 42,215 •2-(3,4-dihydroxyphenyl) ethanol (DPE) •Brefeldin A (BFA) •Resveratrol •Piperine •Curcumin •CFZ&ACY-1215 | ||
EIF2ɑ | Translation initiation | •Fucoidan •Small-molecule inhibitor 42,215 •2-(3,4-dihydroxyphenyl) ethanol (DPE) •Resveratrol •CFZ&ACY-1215 | ||
FOXO | Suppress tumour by promoting cell cycle arrest and apoptosis and preventing the accumulation of damages induced by genotoxic agents and oxidative stress | |||
GRP78 | •Involves in proper protein folding and proteasome degradation of unfolded/misfolded protein •ER Ca2 + binding •Orchestrates the activation of transmembrane ER stress sensors | •Berberine (BBR) •Mung bean trypsin inhibitor (mTI) •Paclitaxel (-)-•Epigallocatechin gallate (EGCG) | •A biomarker for prognosis and early diagnosis of CRC •A biomarker for response of CRC patients to DNA-targeting agents •A biomarker determines response to fluoropyrimidine-based adjuvant chemotherapy | |
IRE1ɑ | •Induce ERAD to facilitate cell survival •Interact with JNK, resulting in cell apoptosis •Promote angiogenesis | •Fucoidan •2-(3,4-dihydroxyphenyl) ethanol (DPE) •CFZ&ACY-1215 | ||
JNK | Induce apoptosis | •2-(3,4-dihydroxyphenyl) ethanol (DPE) •Piperine •Curcumin •CFZ&ACY-1215 | ||
KEAP1 | •Counteract the harmful effects of reactive oxidants •Restore redox balance | |||
MKK4 | Hinder metastasis | |||
NRF2 | Increasing genes involved in antioxidation | [17] | ||
PERK | Is central in the switch between the adaptation and apoptosis | •Small-molecule inhibitor 42,215 •2-(3,4-dihydroxyphenyl) ethanol (DPE) | ||
ROS | Increase cell death | Piperine | ||
s/TAP73 | Promoting CRC cell proliferation and colony formation | [97] | ||
TRAF2 | Interact with tumor necrosis factor receptor and many other signaling molecules | |||
VEGFA | Stimulate angiogenesis | |||
VEGFR2 | Stimulate angiogenesis | |||
XBP1 | Mediated stemness, proliferation and metastasis | Fucoidan | A biomarker in CRC invasion and metastasis |